nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Fingolimod—multiple sclerosis	0.0667	0.213	CbGbCtD
Vardenafil—PDE6H—pineal body—multiple sclerosis	0.0445	0.301	CbGeAlD
Vardenafil—CYP3A4—Methylprednisolone—multiple sclerosis	0.043	0.137	CbGbCtD
Vardenafil—CYP3A5—Dexamethasone—multiple sclerosis	0.0417	0.133	CbGbCtD
Vardenafil—CYP3A4—Triamcinolone—multiple sclerosis	0.0326	0.104	CbGbCtD
Vardenafil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0314	0.1	CbGbCtD
Vardenafil—CYP3A4—Betamethasone—multiple sclerosis	0.028	0.0893	CbGbCtD
Vardenafil—CYP3A4—Prednisolone—multiple sclerosis	0.0276	0.0881	CbGbCtD
Vardenafil—CYP3A4—Prednisone—multiple sclerosis	0.026	0.0832	CbGbCtD
Vardenafil—CYP3A4—Dexamethasone—multiple sclerosis	0.0163	0.0519	CbGbCtD
Vardenafil—PDE6H—retina—multiple sclerosis	0.0134	0.0907	CbGeAlD
Vardenafil—PDE6G—retina—multiple sclerosis	0.0129	0.0873	CbGeAlD
Vardenafil—PDE6H—nervous system—multiple sclerosis	0.00727	0.0493	CbGeAlD
Vardenafil—PDE6H—central nervous system—multiple sclerosis	0.007	0.0474	CbGeAlD
Vardenafil—PDE11A—brain—multiple sclerosis	0.00556	0.0376	CbGeAlD
Vardenafil—PDE6H—brain—multiple sclerosis	0.00556	0.0376	CbGeAlD
Vardenafil—PDE5A—retina—multiple sclerosis	0.00509	0.0345	CbGeAlD
Vardenafil—PDE10A—nervous system—multiple sclerosis	0.00473	0.032	CbGeAlD
Vardenafil—PDE1B—nervous system—multiple sclerosis	0.00468	0.0317	CbGeAlD
Vardenafil—PDE10A—central nervous system—multiple sclerosis	0.00455	0.0308	CbGeAlD
Vardenafil—PDE1B—central nervous system—multiple sclerosis	0.00451	0.0306	CbGeAlD
Vardenafil—PDE10A—cerebellum—multiple sclerosis	0.00445	0.0301	CbGeAlD
Vardenafil—PDE1B—cerebellum—multiple sclerosis	0.00441	0.0299	CbGeAlD
Vardenafil—PDE10A—brain—multiple sclerosis	0.00361	0.0245	CbGeAlD
Vardenafil—PDE1B—brain—multiple sclerosis	0.00358	0.0243	CbGeAlD
Vardenafil—PDE5A—nervous system—multiple sclerosis	0.00277	0.0187	CbGeAlD
Vardenafil—PDE5A—central nervous system—multiple sclerosis	0.00266	0.018	CbGeAlD
Vardenafil—PDE5A—cerebellum—multiple sclerosis	0.0026	0.0176	CbGeAlD
Vardenafil—PDE5A—brain—multiple sclerosis	0.00211	0.0143	CbGeAlD
Vardenafil—CYP3A4—nervous system—multiple sclerosis	0.000862	0.00584	CbGeAlD
Vardenafil—CYP3A4—central nervous system—multiple sclerosis	0.00083	0.00562	CbGeAlD
Vardenafil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000455	0.00118	CcSEcCtD
Vardenafil—Myalgia—Triamcinolone—multiple sclerosis	0.000453	0.00117	CcSEcCtD
Vardenafil—Vomiting—Azathioprine—multiple sclerosis	0.000453	0.00117	CcSEcCtD
Vardenafil—Arthralgia—Methylprednisolone—multiple sclerosis	0.000452	0.00117	CcSEcCtD
Vardenafil—Myalgia—Methylprednisolone—multiple sclerosis	0.000452	0.00117	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—multiple sclerosis	0.000452	0.00117	CcSEcCtD
Vardenafil—Anxiety—Methylprednisolone—multiple sclerosis	0.000451	0.00117	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—multiple sclerosis	0.00045	0.00117	CcSEcCtD
Vardenafil—Infestation—Methotrexate—multiple sclerosis	0.00045	0.00117	CcSEcCtD
Vardenafil—Rash—Azathioprine—multiple sclerosis	0.000449	0.00116	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000449	0.00116	CcSEcCtD
Vardenafil—Dermatitis—Azathioprine—multiple sclerosis	0.000449	0.00116	CcSEcCtD
Vardenafil—Flushing—Prednisone—multiple sclerosis	0.000449	0.00116	CcSEcCtD
Vardenafil—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000448	0.00116	CcSEcCtD
Vardenafil—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000448	0.00116	CcSEcCtD
Vardenafil—Discomfort—Triamcinolone—multiple sclerosis	0.000448	0.00116	CcSEcCtD
Vardenafil—Discomfort—Methylprednisolone—multiple sclerosis	0.000447	0.00116	CcSEcCtD
Vardenafil—Headache—Azathioprine—multiple sclerosis	0.000446	0.00116	CcSEcCtD
Vardenafil—Dry mouth—Triamcinolone—multiple sclerosis	0.000443	0.00115	CcSEcCtD
Vardenafil—Angioedema—Betamethasone—multiple sclerosis	0.000441	0.00114	CcSEcCtD
Vardenafil—Angioedema—Dexamethasone—multiple sclerosis	0.000441	0.00114	CcSEcCtD
Vardenafil—Angiopathy—Prednisone—multiple sclerosis	0.000438	0.00114	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—multiple sclerosis	0.000437	0.00113	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—multiple sclerosis	0.000437	0.00113	CcSEcCtD
Vardenafil—Malaise—Dexamethasone—multiple sclerosis	0.000436	0.00113	CcSEcCtD
Vardenafil—Malaise—Betamethasone—multiple sclerosis	0.000436	0.00113	CcSEcCtD
Vardenafil—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000435	0.00113	CcSEcCtD
Vardenafil—Vertigo—Dexamethasone—multiple sclerosis	0.000434	0.00112	CcSEcCtD
Vardenafil—Vertigo—Betamethasone—multiple sclerosis	0.000434	0.00112	CcSEcCtD
Vardenafil—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000434	0.00112	CcSEcCtD
Vardenafil—Syncope—Dexamethasone—multiple sclerosis	0.000433	0.00112	CcSEcCtD
Vardenafil—Syncope—Betamethasone—multiple sclerosis	0.000433	0.00112	CcSEcCtD
Vardenafil—Infection—Triamcinolone—multiple sclerosis	0.000432	0.00112	CcSEcCtD
Vardenafil—Sweating—Methotrexate—multiple sclerosis	0.000431	0.00112	CcSEcCtD
Vardenafil—Infection—Methylprednisolone—multiple sclerosis	0.000431	0.00112	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—multiple sclerosis	0.000429	0.00111	CcSEcCtD
Vardenafil—Shock—Triamcinolone—multiple sclerosis	0.000428	0.00111	CcSEcCtD
Vardenafil—Insomnia—Prednisolone—multiple sclerosis	0.000427	0.00111	CcSEcCtD
Vardenafil—Shock—Methylprednisolone—multiple sclerosis	0.000427	0.00111	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000426	0.0011	CcSEcCtD
Vardenafil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000425	0.0011	CcSEcCtD
Vardenafil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000425	0.0011	CcSEcCtD
Vardenafil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000425	0.0011	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—multiple sclerosis	0.000424	0.0011	CcSEcCtD
Vardenafil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000424	0.0011	CcSEcCtD
Vardenafil—Paraesthesia—Prednisolone—multiple sclerosis	0.000424	0.0011	CcSEcCtD
Vardenafil—Tachycardia—Triamcinolone—multiple sclerosis	0.000424	0.0011	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—multiple sclerosis	0.000423	0.0011	CcSEcCtD
Vardenafil—Nausea—Azathioprine—multiple sclerosis	0.000423	0.0011	CcSEcCtD
Vardenafil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000423	0.0011	CcSEcCtD
Vardenafil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000421	0.00109	CcSEcCtD
Vardenafil—Erythema—Prednisone—multiple sclerosis	0.000421	0.00109	CcSEcCtD
Vardenafil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00042	0.00109	CcSEcCtD
Vardenafil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000419	0.00109	CcSEcCtD
Vardenafil—Convulsion—Betamethasone—multiple sclerosis	0.000419	0.00108	CcSEcCtD
Vardenafil—Convulsion—Dexamethasone—multiple sclerosis	0.000419	0.00108	CcSEcCtD
Vardenafil—Asthenia—Mitoxantrone—multiple sclerosis	0.000413	0.00107	CcSEcCtD
Vardenafil—Myalgia—Dexamethasone—multiple sclerosis	0.000411	0.00107	CcSEcCtD
Vardenafil—Myalgia—Betamethasone—multiple sclerosis	0.000411	0.00107	CcSEcCtD
Vardenafil—Anxiety—Dexamethasone—multiple sclerosis	0.00041	0.00106	CcSEcCtD
Vardenafil—Anxiety—Betamethasone—multiple sclerosis	0.00041	0.00106	CcSEcCtD
Vardenafil—Discomfort—Dexamethasone—multiple sclerosis	0.000406	0.00105	CcSEcCtD
Vardenafil—Discomfort—Betamethasone—multiple sclerosis	0.000406	0.00105	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—multiple sclerosis	0.000406	0.00105	CcSEcCtD
Vardenafil—Hypotension—Methylprednisolone—multiple sclerosis	0.000405	0.00105	CcSEcCtD
Vardenafil—Pain—Prednisolone—multiple sclerosis	0.000404	0.00105	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—multiple sclerosis	0.000404	0.00105	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—multiple sclerosis	0.000401	0.00104	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000399	0.00103	CcSEcCtD
Vardenafil—Vision blurred—Prednisone—multiple sclerosis	0.000397	0.00103	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—multiple sclerosis	0.000396	0.00103	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000396	0.00103	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000395	0.00102	CcSEcCtD
Vardenafil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000394	0.00102	CcSEcCtD
Vardenafil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000394	0.00102	CcSEcCtD
Vardenafil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000394	0.00102	CcSEcCtD
Vardenafil—Insomnia—Triamcinolone—multiple sclerosis	0.000393	0.00102	CcSEcCtD
Vardenafil—Insomnia—Methylprednisolone—multiple sclerosis	0.000392	0.00102	CcSEcCtD
Vardenafil—Infection—Betamethasone—multiple sclerosis	0.000392	0.00101	CcSEcCtD
Vardenafil—Infection—Dexamethasone—multiple sclerosis	0.000392	0.00101	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisone—multiple sclerosis	0.00039	0.00101	CcSEcCtD
Vardenafil—Paraesthesia—Triamcinolone—multiple sclerosis	0.00039	0.00101	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000389	0.00101	CcSEcCtD
Vardenafil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000389	0.00101	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—multiple sclerosis	0.000389	0.00101	CcSEcCtD
Vardenafil—Shock—Dexamethasone—multiple sclerosis	0.000388	0.001	CcSEcCtD
Vardenafil—Shock—Betamethasone—multiple sclerosis	0.000388	0.001	CcSEcCtD
Vardenafil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000387	0.001	CcSEcCtD
Vardenafil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000387	0.001	CcSEcCtD
Vardenafil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000387	0.001	CcSEcCtD
Vardenafil—Tachycardia—Dexamethasone—multiple sclerosis	0.000385	0.000997	CcSEcCtD
Vardenafil—Tachycardia—Betamethasone—multiple sclerosis	0.000385	0.000997	CcSEcCtD
Vardenafil—Angioedema—Prednisone—multiple sclerosis	0.000384	0.000996	CcSEcCtD
Vardenafil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000383	0.000991	CcSEcCtD
Vardenafil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000382	0.000989	CcSEcCtD
Vardenafil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000381	0.000988	CcSEcCtD
Vardenafil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000381	0.000988	CcSEcCtD
Vardenafil—Malaise—Prednisone—multiple sclerosis	0.000379	0.000983	CcSEcCtD
Vardenafil—Vertigo—Prednisone—multiple sclerosis	0.000378	0.000979	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—multiple sclerosis	0.000377	0.000978	CcSEcCtD
Vardenafil—Syncope—Prednisone—multiple sclerosis	0.000377	0.000977	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—multiple sclerosis	0.000377	0.000976	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—multiple sclerosis	0.000375	0.000971	CcSEcCtD
Vardenafil—Pain—Triamcinolone—multiple sclerosis	0.000372	0.000963	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisone—multiple sclerosis	0.00037	0.000958	CcSEcCtD
Vardenafil—Hypotension—Betamethasone—multiple sclerosis	0.000368	0.000955	CcSEcCtD
Vardenafil—Hypotension—Dexamethasone—multiple sclerosis	0.000368	0.000955	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—multiple sclerosis	0.000366	0.000949	CcSEcCtD
Vardenafil—Vomiting—Mitoxantrone—multiple sclerosis	0.000366	0.000949	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—multiple sclerosis	0.000365	0.000945	CcSEcCtD
Vardenafil—Convulsion—Prednisone—multiple sclerosis	0.000365	0.000944	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000364	0.000943	CcSEcCtD
Vardenafil—Rash—Mitoxantrone—multiple sclerosis	0.000363	0.000941	CcSEcCtD
Vardenafil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000363	0.00094	CcSEcCtD
Vardenafil—Headache—Mitoxantrone—multiple sclerosis	0.000361	0.000935	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000359	0.000931	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000359	0.000931	CcSEcCtD
Vardenafil—Myalgia—Prednisone—multiple sclerosis	0.000358	0.000928	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—multiple sclerosis	0.000358	0.000928	CcSEcCtD
Vardenafil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000358	0.000928	CcSEcCtD
Vardenafil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000357	0.000926	CcSEcCtD
Vardenafil—Anxiety—Prednisone—multiple sclerosis	0.000357	0.000925	CcSEcCtD
Vardenafil—Insomnia—Betamethasone—multiple sclerosis	0.000357	0.000924	CcSEcCtD
Vardenafil—Insomnia—Dexamethasone—multiple sclerosis	0.000357	0.000924	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000356	0.000922	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000355	0.000919	CcSEcCtD
Vardenafil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000354	0.000917	CcSEcCtD
Vardenafil—Paraesthesia—Betamethasone—multiple sclerosis	0.000354	0.000917	CcSEcCtD
Vardenafil—Discomfort—Prednisone—multiple sclerosis	0.000354	0.000917	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—multiple sclerosis	0.000354	0.000917	CcSEcCtD
Vardenafil—Erythema—Methotrexate—multiple sclerosis	0.000352	0.000911	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000348	0.000902	CcSEcCtD
Vardenafil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000347	0.000899	CcSEcCtD
Vardenafil—Dyspepsia—Betamethasone—multiple sclerosis	0.000347	0.000899	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000343	0.00089	CcSEcCtD
Vardenafil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000343	0.000888	CcSEcCtD
Vardenafil—Nausea—Mitoxantrone—multiple sclerosis	0.000342	0.000886	CcSEcCtD
Vardenafil—Infection—Prednisone—multiple sclerosis	0.000341	0.000884	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00034	0.000882	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00034	0.000882	CcSEcCtD
Vardenafil—Back pain—Methotrexate—multiple sclerosis	0.00034	0.000881	CcSEcCtD
Vardenafil—Shock—Prednisone—multiple sclerosis	0.000338	0.000875	CcSEcCtD
Vardenafil—Pain—Betamethasone—multiple sclerosis	0.000337	0.000874	CcSEcCtD
Vardenafil—Pain—Dexamethasone—multiple sclerosis	0.000337	0.000874	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—multiple sclerosis	0.000337	0.000872	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—multiple sclerosis	0.000335	0.000868	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—multiple sclerosis	0.000334	0.000864	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000332	0.00086	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—multiple sclerosis	0.000331	0.000859	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000326	0.000845	CcSEcCtD
Vardenafil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000325	0.000842	CcSEcCtD
Vardenafil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000325	0.000842	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000322	0.000835	CcSEcCtD
Vardenafil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000322	0.000835	CcSEcCtD
Vardenafil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00032	0.000829	CcSEcCtD
Vardenafil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000319	0.000828	CcSEcCtD
Vardenafil—Malaise—Methotrexate—multiple sclerosis	0.000317	0.000821	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—multiple sclerosis	0.000316	0.000818	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000313	0.00081	CcSEcCtD
Vardenafil—Dizziness—Prednisolone—multiple sclerosis	0.000312	0.00081	CcSEcCtD
Vardenafil—Asthenia—Triamcinolone—multiple sclerosis	0.000312	0.000808	CcSEcCtD
Vardenafil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000312	0.000808	CcSEcCtD
Vardenafil—Abdominal pain—Betamethasone—multiple sclerosis	0.000312	0.000808	CcSEcCtD
Vardenafil—Asthenia—Methylprednisolone—multiple sclerosis	0.000311	0.000806	CcSEcCtD
Vardenafil—Insomnia—Prednisone—multiple sclerosis	0.000311	0.000805	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—multiple sclerosis	0.000308	0.000799	CcSEcCtD
Vardenafil—Pruritus—Triamcinolone—multiple sclerosis	0.000307	0.000797	CcSEcCtD
Vardenafil—Pruritus—Methylprednisolone—multiple sclerosis	0.000307	0.000795	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—multiple sclerosis	0.000305	0.000789	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—multiple sclerosis	0.000302	0.000783	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—multiple sclerosis	0.000299	0.000776	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—multiple sclerosis	0.000299	0.000776	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—multiple sclerosis	0.000299	0.000776	CcSEcCtD
Vardenafil—Rash—Prednisolone—multiple sclerosis	0.000298	0.000772	CcSEcCtD
Vardenafil—Dermatitis—Prednisolone—multiple sclerosis	0.000298	0.000771	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000297	0.00077	CcSEcCtD
Vardenafil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000297	0.000769	CcSEcCtD
Vardenafil—Headache—Prednisolone—multiple sclerosis	0.000296	0.000767	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—multiple sclerosis	0.000296	0.000766	CcSEcCtD
Vardenafil—Dizziness—Triamcinolone—multiple sclerosis	0.000287	0.000744	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000287	0.000743	CcSEcCtD
Vardenafil—Dizziness—Methylprednisolone—multiple sclerosis	0.000287	0.000743	CcSEcCtD
Vardenafil—Infection—Methotrexate—multiple sclerosis	0.000285	0.000739	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—multiple sclerosis	0.000283	0.000733	CcSEcCtD
Vardenafil—Asthenia—Dexamethasone—multiple sclerosis	0.000283	0.000733	CcSEcCtD
Vardenafil—Asthenia—Betamethasone—multiple sclerosis	0.000283	0.000733	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000281	0.000729	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000281	0.000727	CcSEcCtD
Vardenafil—Nausea—Prednisolone—multiple sclerosis	0.000281	0.000727	CcSEcCtD
Vardenafil—Pruritus—Betamethasone—multiple sclerosis	0.000279	0.000723	CcSEcCtD
Vardenafil—Pruritus—Dexamethasone—multiple sclerosis	0.000279	0.000723	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—multiple sclerosis	0.000279	0.000722	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000277	0.000719	CcSEcCtD
Vardenafil—Vomiting—Triamcinolone—multiple sclerosis	0.000276	0.000716	CcSEcCtD
Vardenafil—Vomiting—Methylprednisolone—multiple sclerosis	0.000276	0.000714	CcSEcCtD
Vardenafil—Rash—Triamcinolone—multiple sclerosis	0.000274	0.00071	CcSEcCtD
Vardenafil—Dermatitis—Triamcinolone—multiple sclerosis	0.000274	0.000709	CcSEcCtD
Vardenafil—Rash—Methylprednisolone—multiple sclerosis	0.000273	0.000708	CcSEcCtD
Vardenafil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000273	0.000708	CcSEcCtD
Vardenafil—Headache—Triamcinolone—multiple sclerosis	0.000272	0.000705	CcSEcCtD
Vardenafil—Headache—Methylprednisolone—multiple sclerosis	0.000272	0.000704	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—multiple sclerosis	0.000271	0.000703	CcSEcCtD
Vardenafil—Diarrhoea—Betamethasone—multiple sclerosis	0.00027	0.000699	CcSEcCtD
Vardenafil—Diarrhoea—Dexamethasone—multiple sclerosis	0.00027	0.000699	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—multiple sclerosis	0.000268	0.000695	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000261	0.000677	CcSEcCtD
Vardenafil—Dizziness—Dexamethasone—multiple sclerosis	0.000261	0.000675	CcSEcCtD
Vardenafil—Dizziness—Betamethasone—multiple sclerosis	0.000261	0.000675	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—multiple sclerosis	0.00026	0.000672	CcSEcCtD
Vardenafil—Nausea—Triamcinolone—multiple sclerosis	0.000258	0.000669	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—multiple sclerosis	0.000258	0.000668	CcSEcCtD
Vardenafil—Nausea—Methylprednisolone—multiple sclerosis	0.000258	0.000667	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—multiple sclerosis	0.000256	0.000663	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—multiple sclerosis	0.000255	0.000661	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—multiple sclerosis	0.000253	0.000655	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—multiple sclerosis	0.000253	0.000654	CcSEcCtD
Vardenafil—Vomiting—Dexamethasone—multiple sclerosis	0.000251	0.000649	CcSEcCtD
Vardenafil—Vomiting—Betamethasone—multiple sclerosis	0.000251	0.000649	CcSEcCtD
Vardenafil—Rash—Dexamethasone—multiple sclerosis	0.000249	0.000644	CcSEcCtD
Vardenafil—Rash—Betamethasone—multiple sclerosis	0.000249	0.000644	CcSEcCtD
Vardenafil—Dermatitis—Betamethasone—multiple sclerosis	0.000248	0.000643	CcSEcCtD
Vardenafil—Dermatitis—Dexamethasone—multiple sclerosis	0.000248	0.000643	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000248	0.000642	CcSEcCtD
Vardenafil—Headache—Betamethasone—multiple sclerosis	0.000247	0.00064	CcSEcCtD
Vardenafil—Headache—Dexamethasone—multiple sclerosis	0.000247	0.00064	CcSEcCtD
Vardenafil—Asthenia—Prednisone—multiple sclerosis	0.000246	0.000638	CcSEcCtD
Vardenafil—Pain—Methotrexate—multiple sclerosis	0.000245	0.000636	CcSEcCtD
Vardenafil—Pruritus—Prednisone—multiple sclerosis	0.000243	0.000629	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000236	0.000613	CcSEcCtD
Vardenafil—Diarrhoea—Prednisone—multiple sclerosis	0.000235	0.000609	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000235	0.000608	CcSEcCtD
Vardenafil—Nausea—Betamethasone—multiple sclerosis	0.000234	0.000607	CcSEcCtD
Vardenafil—Nausea—Dexamethasone—multiple sclerosis	0.000234	0.000607	CcSEcCtD
Vardenafil—Dizziness—Prednisone—multiple sclerosis	0.000227	0.000588	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—multiple sclerosis	0.000227	0.000588	CcSEcCtD
Vardenafil—Vomiting—Prednisone—multiple sclerosis	0.000218	0.000566	CcSEcCtD
Vardenafil—Rash—Prednisone—multiple sclerosis	0.000217	0.000561	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—multiple sclerosis	0.000216	0.00056	CcSEcCtD
Vardenafil—Headache—Prednisone—multiple sclerosis	0.000215	0.000557	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—multiple sclerosis	0.000211	0.000548	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—multiple sclerosis	0.000206	0.000533	CcSEcCtD
Vardenafil—Nausea—Prednisone—multiple sclerosis	0.000204	0.000528	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—multiple sclerosis	0.000203	0.000526	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—multiple sclerosis	0.000196	0.000509	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—multiple sclerosis	0.00019	0.000492	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—multiple sclerosis	0.000182	0.000473	CcSEcCtD
Vardenafil—Rash—Methotrexate—multiple sclerosis	0.000181	0.000469	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—multiple sclerosis	0.000181	0.000468	CcSEcCtD
Vardenafil—Headache—Methotrexate—multiple sclerosis	0.00018	0.000466	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—CD28—multiple sclerosis	0.000176	0.00115	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MALT1—multiple sclerosis	0.000174	0.00113	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000173	0.00113	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCR2—multiple sclerosis	0.000172	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRF5—multiple sclerosis	0.000171	0.00112	CbGpPWpGaD
Vardenafil—Nausea—Methotrexate—multiple sclerosis	0.00017	0.000442	CcSEcCtD
Vardenafil—PDE1B—Signaling by FGFR in disease—MAPK1—multiple sclerosis	0.00017	0.00111	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—MAPK1—multiple sclerosis	0.00017	0.00111	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CD86—multiple sclerosis	0.000169	0.0011	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—MAPK1—multiple sclerosis	0.000169	0.0011	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000167	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—MAPK1—multiple sclerosis	0.000167	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—MAPK1—multiple sclerosis	0.000166	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RPL5—multiple sclerosis	0.000166	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	0.000166	0.00108	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TGFB1—multiple sclerosis	0.000166	0.00108	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—POMC—multiple sclerosis	0.000165	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2RA—multiple sclerosis	0.000164	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000164	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-G—multiple sclerosis	0.000163	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRF8—multiple sclerosis	0.000163	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFIH1—multiple sclerosis	0.000163	0.00107	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CNR1—multiple sclerosis	0.000163	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000163	0.00106	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CCR5—multiple sclerosis	0.000163	0.00106	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—MAPK1—multiple sclerosis	0.000162	0.00106	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—POMC—multiple sclerosis	0.000162	0.00106	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCL2—multiple sclerosis	0.000161	0.00105	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL10—multiple sclerosis	0.000161	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SLC11A1—multiple sclerosis	0.000159	0.00104	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CNR1—multiple sclerosis	0.000159	0.00104	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HLA-A—multiple sclerosis	0.000159	0.00104	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.000157	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HLA-B—multiple sclerosis	0.000157	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RGS1—multiple sclerosis	0.000156	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TNFAIP3—multiple sclerosis	0.000153	0.000998	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000152	0.000992	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	0.000151	0.000983	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.00015	0.000981	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—IL6—multiple sclerosis	0.00015	0.000979	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GPR65—multiple sclerosis	0.000148	0.000967	CbGpPWpGaD
Vardenafil—PDE6G—Disease—APOE—multiple sclerosis	0.000148	0.000966	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR2—multiple sclerosis	0.000148	0.000965	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—multiple sclerosis	0.000148	0.000964	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—multiple sclerosis	0.000148	0.000964	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL10—multiple sclerosis	0.000147	0.000959	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—POMC—multiple sclerosis	0.000147	0.000959	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TYK2—multiple sclerosis	0.000146	0.000956	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—MAPK1—multiple sclerosis	0.000145	0.000945	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—MAPK1—multiple sclerosis	0.000145	0.000945	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCL2—multiple sclerosis	0.000144	0.000938	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL10—multiple sclerosis	0.000143	0.000935	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—IL6—multiple sclerosis	0.000141	0.00092	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CD86—multiple sclerosis	0.000141	0.000917	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—IL6—multiple sclerosis	0.00014	0.000915	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—IL6—multiple sclerosis	0.00014	0.000911	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—IL6—multiple sclerosis	0.000139	0.000906	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL5—multiple sclerosis	0.000138	0.000903	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD28—multiple sclerosis	0.000138	0.000898	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CNR1—multiple sclerosis	0.000136	0.000891	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR1—multiple sclerosis	0.000136	0.000885	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL13—multiple sclerosis	0.000136	0.000885	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000135	0.000883	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTPRC—multiple sclerosis	0.000135	0.000882	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CCR2—multiple sclerosis	0.000135	0.000882	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—IL2—multiple sclerosis	0.000134	0.000876	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CD80—multiple sclerosis	0.000134	0.000874	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—TLR4—multiple sclerosis	0.000133	0.00087	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000132	0.000863	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SRM—multiple sclerosis	0.000132	0.000863	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—IL6—multiple sclerosis	0.000131	0.000853	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—IL6—multiple sclerosis	0.000131	0.000853	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-DPB1—multiple sclerosis	0.000131	0.000852	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TYK2—multiple sclerosis	0.000131	0.000852	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—IL6—multiple sclerosis	0.00013	0.000845	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CD86—multiple sclerosis	0.000129	0.000839	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—IL6—multiple sclerosis	0.000128	0.000838	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPP1—multiple sclerosis	0.000128	0.000836	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—IL6—multiple sclerosis	0.000128	0.000834	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—STAT3—multiple sclerosis	0.000127	0.000832	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD28—multiple sclerosis	0.000127	0.000829	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL5—multiple sclerosis	0.000127	0.000826	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ITGA4—multiple sclerosis	0.000126	0.00082	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD40—multiple sclerosis	0.000126	0.00082	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CD86—multiple sclerosis	0.000125	0.000817	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNB1—multiple sclerosis	0.000125	0.000814	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCR5—multiple sclerosis	0.000125	0.000813	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTLA4—multiple sclerosis	0.000124	0.000808	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL5—multiple sclerosis	0.000123	0.000805	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CD80—multiple sclerosis	0.000123	0.000802	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000123	0.000802	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2RA—multiple sclerosis	0.000123	0.000802	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—POMC—multiple sclerosis	0.000123	0.0008	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL2—multiple sclerosis	0.000122	0.000795	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—IL2—multiple sclerosis	0.00012	0.000781	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ALB—multiple sclerosis	0.000118	0.000772	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPP1—multiple sclerosis	0.000117	0.000765	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000116	0.00076	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—MAPK1—multiple sclerosis	0.000116	0.000756	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	0.000116	0.000755	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPP1—multiple sclerosis	0.000114	0.000745	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCR5—multiple sclerosis	0.000114	0.000744	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—APOE—multiple sclerosis	0.000113	0.00074	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TYK2—multiple sclerosis	0.000113	0.000738	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2RA—multiple sclerosis	0.000112	0.000733	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCR5—multiple sclerosis	0.000111	0.000725	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2RA—multiple sclerosis	0.000109	0.000714	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—VCAM1—multiple sclerosis	0.000109	0.000713	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-DQA1—multiple sclerosis	0.000109	0.000711	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL2—multiple sclerosis	0.000109	0.000709	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000107	0.0007	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000106	0.00069	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000105	0.000685	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—TYK2—multiple sclerosis	0.000104	0.000677	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APOE—multiple sclerosis	0.000104	0.000677	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000103	0.000675	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CD80—multiple sclerosis	0.000103	0.000669	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CD4—multiple sclerosis	0.000102	0.000667	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-DQB1—multiple sclerosis	0.000102	0.000665	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APOE—multiple sclerosis	0.000101	0.000659	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD86—multiple sclerosis	9.82e-05	0.000641	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—multiple sclerosis	9.74e-05	0.000636	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL3—multiple sclerosis	9.66e-05	0.00063	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD40LG—multiple sclerosis	9.63e-05	0.000628	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2—multiple sclerosis	9.59e-05	0.000626	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL2—multiple sclerosis	9.53e-05	0.000622	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR5—multiple sclerosis	9.53e-05	0.000622	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD8A—multiple sclerosis	9.52e-05	0.000621	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2RA—multiple sclerosis	9.39e-05	0.000613	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CD4—multiple sclerosis	9.39e-05	0.000613	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CD80—multiple sclerosis	9.38e-05	0.000612	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—MAPK1—multiple sclerosis	9.32e-05	0.000608	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	9.31e-05	0.000608	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	9.31e-05	0.000608	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTGER4—multiple sclerosis	9.3e-05	0.000607	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-B—multiple sclerosis	9.16e-05	0.000598	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PGR—multiple sclerosis	9.16e-05	0.000598	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CD80—multiple sclerosis	9.14e-05	0.000596	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD86—multiple sclerosis	9.06e-05	0.000592	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCR3—multiple sclerosis	8.98e-05	0.000586	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—multiple sclerosis	8.91e-05	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—multiple sclerosis	8.9e-05	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CD28—multiple sclerosis	8.9e-05	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR2—multiple sclerosis	8.74e-05	0.00057	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL2—multiple sclerosis	8.72e-05	0.000569	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—multiple sclerosis	8.68e-05	0.000567	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TYK2—multiple sclerosis	8.65e-05	0.000565	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2RA—multiple sclerosis	8.58e-05	0.00056	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPC5—multiple sclerosis	8.52e-05	0.000556	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL2—multiple sclerosis	8.49e-05	0.000554	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-A—multiple sclerosis	8.49e-05	0.000554	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK1—multiple sclerosis	8.31e-05	0.000542	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—multiple sclerosis	8.2e-05	0.000535	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CNR1—multiple sclerosis	8.06e-05	0.000526	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CCR5—multiple sclerosis	8.04e-05	0.000525	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TYK2—multiple sclerosis	7.91e-05	0.000517	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STAT3—multiple sclerosis	7.91e-05	0.000516	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HLA-A—multiple sclerosis	7.83e-05	0.000511	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TLR4—multiple sclerosis	7.76e-05	0.000506	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HLA-DRB1—multiple sclerosis	7.75e-05	0.000506	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TYK2—multiple sclerosis	7.71e-05	0.000503	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—multiple sclerosis	7.48e-05	0.000488	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—multiple sclerosis	7.45e-05	0.000486	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ICAM1—multiple sclerosis	7.44e-05	0.000486	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—multiple sclerosis	7.35e-05	0.00048	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK1—multiple sclerosis	7.34e-05	0.000479	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—multiple sclerosis	7.34e-05	0.000479	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOE—multiple sclerosis	7.31e-05	0.000477	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL2—multiple sclerosis	7.29e-05	0.000476	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL10—multiple sclerosis	7.26e-05	0.000474	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—multiple sclerosis	7.2e-05	0.00047	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK1—multiple sclerosis	7.19e-05	0.000469	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—multiple sclerosis	7.16e-05	0.000468	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD80—multiple sclerosis	7.16e-05	0.000467	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—RRM1—multiple sclerosis	7.06e-05	0.000461	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—multiple sclerosis	6.81e-05	0.000445	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TYK2—multiple sclerosis	6.62e-05	0.000432	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD80—multiple sclerosis	6.61e-05	0.000432	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK1—multiple sclerosis	6.61e-05	0.000431	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—multiple sclerosis	6.59e-05	0.00043	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—multiple sclerosis	6.42e-05	0.000419	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—multiple sclerosis	6.39e-05	0.000417	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CD86—multiple sclerosis	6.35e-05	0.000414	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL5—multiple sclerosis	6.25e-05	0.000408	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—multiple sclerosis	6.23e-05	0.000407	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SRM—multiple sclerosis	6.15e-05	0.000401	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—multiple sclerosis	6.07e-05	0.000396	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—multiple sclerosis	6.06e-05	0.000396	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—multiple sclerosis	6.06e-05	0.000395	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TYK2—multiple sclerosis	6.05e-05	0.000395	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—multiple sclerosis	5.79e-05	0.000378	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.7e-05	0.000372	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNG—multiple sclerosis	5.66e-05	0.000369	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—multiple sclerosis	5.63e-05	0.000367	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR5—multiple sclerosis	5.63e-05	0.000367	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—multiple sclerosis	5.62e-05	0.000367	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TYK2—multiple sclerosis	5.58e-05	0.000364	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2RA—multiple sclerosis	5.55e-05	0.000362	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—multiple sclerosis	5.54e-05	0.000362	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—multiple sclerosis	5.53e-05	0.000361	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK1—multiple sclerosis	5.51e-05	0.000359	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—multiple sclerosis	5.51e-05	0.000359	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD4—multiple sclerosis	5.47e-05	0.000357	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—multiple sclerosis	5.4e-05	0.000352	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—multiple sclerosis	5.15e-05	0.000336	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—multiple sclerosis	5.14e-05	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—multiple sclerosis	5.12e-05	0.000334	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—multiple sclerosis	5.08e-05	0.000331	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—multiple sclerosis	5.05e-05	0.00033	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD4—multiple sclerosis	5.05e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK1—multiple sclerosis	5.04e-05	0.000329	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—multiple sclerosis	5.03e-05	0.000328	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—multiple sclerosis	5.02e-05	0.000327	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—multiple sclerosis	5.01e-05	0.000327	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK1—multiple sclerosis	4.91e-05	0.00032	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CD80—multiple sclerosis	4.63e-05	0.000302	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—multiple sclerosis	4.4e-05	0.000287	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.33e-05	0.000283	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.33e-05	0.000283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—multiple sclerosis	4.3e-05	0.000281	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—multiple sclerosis	4.23e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—multiple sclerosis	4.23e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK1—multiple sclerosis	4.21e-05	0.000275	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—multiple sclerosis	4.05e-05	0.000265	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.96e-05	0.000258	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TYK2—multiple sclerosis	3.91e-05	0.000255	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—multiple sclerosis	3.91e-05	0.000255	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—multiple sclerosis	3.87e-05	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK1—multiple sclerosis	3.85e-05	0.000251	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—multiple sclerosis	3.77e-05	0.000246	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—multiple sclerosis	3.63e-05	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—multiple sclerosis	3.62e-05	0.000236	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK1—multiple sclerosis	3.55e-05	0.000232	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.28e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—multiple sclerosis	3.25e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—multiple sclerosis	3.24e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—multiple sclerosis	3.08e-05	0.000201	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—multiple sclerosis	2.96e-05	0.000193	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—multiple sclerosis	2.74e-05	0.000179	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—multiple sclerosis	2.73e-05	0.000178	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—multiple sclerosis	2.54e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—multiple sclerosis	2.54e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK1—multiple sclerosis	2.49e-05	0.000162	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—multiple sclerosis	2.44e-05	0.000159	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—multiple sclerosis	2.1e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—multiple sclerosis	1.91e-05	0.000125	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—multiple sclerosis	1.91e-05	0.000125	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.88e-05	0.000123	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—multiple sclerosis	1.13e-05	7.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—multiple sclerosis	9.74e-06	6.36e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—multiple sclerosis	8.88e-06	5.8e-05	CbGpPWpGaD
